Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06067412Completed
Randomised, open-label trial of levetiracetam in status epilepticus (SE) (2 arms), sponsored by Shaheed Zulfiqar Ali Bhutto Medical University. Primary endpoint: Efficacy of seizure control at 24 hours. Started Aug 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06067412.